Browsing Category
Captisol
Microwave-assisted β-cyclodextrin/chrysin inclusion complexation: An economical and green strategy…
Highlights
• 1:1 solid inclusion complex (IC) of chrysin with β-cyclodextrin prepared.
• Microwave irradiation method is time-saving and environmentally benign.
• Microwaved IC has highest drug content, solubility and hemocompatibility.
• Microwaved IC displayed superior…
Read More...
Read More...
Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
Cannabis has been used in pain management since 2900 BC. In the 20th century, synthetic cannabinoids began to emerge, thus opening the way for improved efficacy. The search for new forms of synthetic cannabinoids continues and, as such, the aim of this review is to provide a comprehensive tool for…
Read More...
Read More...
Vireo Health teams with Ligand on cannabis delivery methods
Article by Omar Sacirbay - mjbizmagazine
As an emergency room physician and the founding CEO of Vireo Health, a multistate marijuana company based in Minnesota, Kyle Kingsley had thought extensively about how cannabinoids could replace opioids for pain relief.
So, in 2015, when Vireo’s…
Read More...
Read More...
Scale-up of electrospinning technology: Applications in the pharmaceutical industry
Electrospinning (ES) was originally reported in 1899 and the technology has been used since for the fabrication of con- tinuous fibers (Cooley, 1899).
Beginning from the 1980s and particularly during the recent decade, the technology has gained increasing attention. Possibly this can be…
Read More...
Read More...
Cyclodextrins: Emerging Medicines of the New Millennium
Cyclodextrins, since their discovery in the late 19th century, were mainly regarded as excipients. Nevertheless, developments in cyclodextrin research have shown that some of these hosts can capture and include biomolecules, highlighting fatty acids and cholesterol, which implies that they are not…
Read More...
Read More...
Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and…
Age-related macular degeneration (AMD) is the leading cause of severe vision impairment in patients over the age of 60 years.
Choroidal neovascularization (CNV) is the hallmark of neovascular AMD and vascular endothelial growth factor (VEGF) plays a causal role in the formation of CNV. Although…
Read More...
Read More...
Controlled Delivery of Dutasteride Using Dissolvable Microarrays: Initial Formulation and In-vivo…
Dutasteride is prescribed as a once daily oral capsule for the treatment of symptomatic benign prostatic hyperplasia.
As an alternative and patient focused drug product, this laboratory evaluated the potential to deliver dutasteride in a controlled/sustained manner when formulated as a…
Read More...
Read More...
Improved oral bioavailability of anticancer drug tamoxifen through complexation with water soluble…
Tamoxifen (TMX), a class II antiestrogen drug consistent with the biopharmaceutical classification system, shows low plasma levels leading to therapeutic failure as a result of poor aqueous solubility.
Complexation with multifunctional excipients cyclodextrins (CDs) is an effective technique to…
Read More...
Read More...
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Ligand Pharmaceuticals Incorporated presented positive results from a Phase 1 clinical trial of its Captisol-enabled (CE) Iohexol program at ASN Kidney Week 2019 in Washington, D.C.
The CE-Iohexol program was established in January 2018 to develop a Captisol-enabled, next-generation contrast…
Read More...
Read More...
Inclusion complexes of atorvastatin calcium–sulfobutyl ether β cyclodextrin with enhanced…
The aim of present study was to explore the impact of Atorvastatin (ATR) Sulfobutylether beta-cyclodextrin complex (ATR-SBE-β-CD) on ATR dissolution behavior.
Various batches of inclusion complexes were formulated using various drug: polymer ratios (1:1, 1:3, and 1:5); using β-CD and SBE-β-CD and…
Read More...
Read More...